Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Open Access Research article

Nafamostat mesylate, a serine protease inhibitor, demonstrates novel antimicrobial properties and effectiveness in Chlamydia-induced arthritis

Robert D Inman* and Basil Chiu

Arthritis Research & Therapy 2012, 14:R150  doi:10.1186/ar3886

Article Metrics

2716
Total accesses

Article metric FAQ

Accesses  

  • Last 30 days: 53 accesses
  • Last 365 days: 697 accesses
  • All time: 2716 accesses

These numbers are accesses on BioMed Central websites only, and an underestimate of total usage. More information